CRD-102 for Right Heart Failure in Patients With Left Ventricular Assist Devices
Phase of Trial: Phase I/II
Latest Information Update: 26 Jun 2019
Price : $35 *
At a glance
- Drugs CRD 102 (Primary)
- Indications Heart failure
- Focus Adverse reactions
- Sponsors Cardiora
- 24 Jun 2019 Status changed from recruiting to completed.
- 06 Apr 2019 Results (n=6) presented at the 39th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation.
- 04 Feb 2019 Planned End Date changed from 1 Aug 2018 to 1 May 2019.